[6] [9] According to NICE guidance (NG28), GLP-1 receptor agonists are recommended as part of a comprehensive treatment strategy for type 2 diabetes that includes dietary modification, increased physical activity, and other glucose-lowering therapies when appropriate
ReSM GLP-1 Postbiotic uses a postbiotic approach similar to one component of GLP-1 Complete but as the primary mechanism rather than one of four ingredients
Continuing on to discontinuation rates we see another very interesting nugget that I have bolded below: Discontinuation rates due to adverse events were 12.2% and 18.2% with retatrutide 9 mg and 12 mg, respectively, compared to 4.0% with placebo
If needed, consult your doctor about taking supplements to address deficiencies
With its dual action on incretin hormones, oral tirzepatide offers a novel approach to managing weight and improving metabolic health
It directly predicts which compounds will work best for which goals